The Pennant Group’s (PNTG) Overweight Rating Reiterated at Stephens

Stephens reaffirmed their overweight rating on shares of The Pennant Group (NASDAQ:PNTGFree Report) in a research report sent to investors on Wednesday, Benzinga reports. The firm currently has a $40.00 price objective on the stock.

A number of other equities research analysts also recently issued reports on the company. Truist Financial increased their price target on The Pennant Group from $34.00 to $38.00 and gave the stock a hold rating in a research report on Monday, October 7th. Oppenheimer increased their price target on The Pennant Group from $28.00 to $34.00 and gave the stock an outperform rating in a research report on Thursday, August 8th.

View Our Latest Report on The Pennant Group

The Pennant Group Price Performance

Shares of NASDAQ PNTG opened at $33.79 on Wednesday. The business’s 50 day moving average price is $33.03 and its two-hundred day moving average price is $26.65. The company has a market cap of $1.02 billion, a PE ratio of 53.64, a price-to-earnings-growth ratio of 3.48 and a beta of 2.01. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.48. The Pennant Group has a twelve month low of $10.31 and a twelve month high of $37.13.

The Pennant Group (NASDAQ:PNTGGet Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. The Pennant Group had a return on equity of 13.74% and a net margin of 3.16%. The company had revenue of $168.75 million for the quarter, compared to the consensus estimate of $156.71 million. On average, analysts predict that The Pennant Group will post 0.75 EPS for the current year.

Institutional Investors Weigh In On The Pennant Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Covestor Ltd boosted its holdings in shares of The Pennant Group by 3,805.6% during the 1st quarter. Covestor Ltd now owns 1,406 shares of the company’s stock valued at $28,000 after acquiring an additional 1,370 shares in the last quarter. USA Financial Formulas acquired a new stake in shares of The Pennant Group during the 3rd quarter valued at $121,000. Principal Financial Group Inc. acquired a new stake in shares of The Pennant Group during the 1st quarter valued at $197,000. Acadian Asset Management LLC acquired a new stake in shares of The Pennant Group during the 1st quarter valued at $218,000. Finally, Bailard Inc. acquired a new stake in shares of The Pennant Group during the 2nd quarter valued at $253,000. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

See Also

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.